Health economic evaluation of treatment strategies with biologic agents for rheumatoid arthritis
| Project/Area Number |
23790585
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Medical sociology
|
|---|
| Research Institution | Niigata University of Health and Welfare |
|---|
Principal Investigator |
MORIWAKI KENSUKE 新潟医療福祉大学, 公私立大学の部局等, 講師 (10514862)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 医療経済学 / 国内研究 |
|---|
| Research Abstract |
In view of health economic evaluations of rheumatoid arthritis in Japan, following studies were conducted: (1) A model structure which reflects clinical practice in Japan was considered through a systematic review of published articles. Also availability of data for the estimation of model parameter such as QOL, cost, and clinical efficacy was examined. (2) Based on data derived from a cross sectional survey, the relation between RA disease activity and QOL or cost were analyzed. Also mapping models used for health economic evaluation were developed.
|
Report
(4 results)
Research Products
(7 results)
